The Research To Cure PSC
For more than a decade, Dr. Cox has spearheaded research by gastroenterologists, microbiologists, and immunologists to understand how vancomycin treats PSC. The research team believes they are within reach of finding the cause, knowledge which could lead to a cure. The Children’s PSC Foundation is dedicated to funding the completion of this research, alleviating the suffering of thousands of children with PSC throughout the world, and seeing the day when PSC is solved and cured. Compared to better-known diseases, PSC may seem insignificant, but to the hundreds of children and their parents who receive this diagnosis every year in the United States, it is devastating.
We welcome you on our journey towards the cure, and thank you for supporting us in our endeavors.
Dr. Cox and the other researchers are in the process of demonstrating and explaining to the scientific and medical community what we already know (see The Children) – that oral vancomycin can stop the progression of PSC.
DNA identification of gut bacteria in PSC patients before and after vancomycin, as well as in healthy individuals, is already underway. In many cases, children must fly in from other areas. They need to be guided through the process of signing up for the study and undergo tests while at Stanford.
To continue the research already under way, some $250,000 needs to be raised as soon as possible. To complete the project the number is closer to $500,000. The cost is small compared to the savings in suffering and the cost of treatment. To put it in perspective, the cost of a single liver transplant in the U.S. is over $1 million. And, lives will be saved if liver transplants can be avoided.
Your contribution will make a difference in the lives of children living with Primary Sclerosing Cholangitis (PSC).
Funds raised will support Primary Sclerosing Cholangitis (PSC) research. Your gift is tax deductible. Children’s PSC Foundation is a non-profit, tax-exempt entity pursuant to Section 501(c)3 Federal Tax ID # 26-4814733.